4.6 Article

The Evolving Concept of Complete Resection in Lung Cancer Surgery

Related references

Note: Only part of the references are listed.
Article Oncology

Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study

Raymond U. Osarogiagbon et al.

Summary: The study showed that using a lymph node specimen collection kit significantly improved the quality of pathologic nodal staging in lung cancer surgery and may lead to improved survival rates, without an increase in complication rates or mortality.

JOURNAL OF THORACIC ONCOLOGY (2021)

Article Oncology

A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC

Jae Kwang Yun et al.

Summary: This study aimed to validate the R descriptors proposed by IASLC for patients with pN2 NSCLC, and found that reclassification based on IASLC criteria can more accurately assess the prognosis of patients under the same resection criteria.

JOURNAL OF THORACIC ONCOLOGY (2021)

Article Oncology

Prognostic impact of extranodal extension in patients with pN1-N2 lung adenocarcinoma

Kotaro Nomura et al.

Summary: Among patients undergoing surgical resection for lung adenocarcinoma with lymph node involvement, extranodal extension was identified as the most significant prognostic factor among different morphological patterns of lymph node involvement. Other clinicopathological factors such as invasive size, history of chemotherapy, and presence of mutations also played a role in influencing the prognosis of lung adenocarcinoma patients.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Review Oncology

Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy-The Role of Liquid Biopsy in Unraveling the Puzzle

Elien Augustus et al.

Summary: Immunotherapy has revolutionized the treatment landscape for non-small cell lung cancer (NSCLC), but only a subset of patients benefit from it. Liquid biopsy serves as an alternative method to select patients suitable for immunotherapy and monitor disease progression, offering advantages such as repetitive sampling in clinical practice. This review explores the challenges and opportunities of liquid biopsy-based prognostic and predictive biomarkers in NSCLC patients receiving immunotherapy.

CANCERS (2021)

Review Oncology

Promising Role of Circulating Tumor Cells in the Management of SCLC

Antonella De Luca et al.

Summary: Despite the recent approval of immune-checkpoint inhibitors, therapeutic strategies for small-cell lung cancer (SCLC) patients have not changed for decades due to the aggressiveness of the disease and lack of active treatments. Identifying biomarkers is crucial for guiding therapeutic decisions. Circulating tumor cells (CTCs) are a promising tool for improving clinical management and understanding SCLC biology.

CANCERS (2021)

Article Oncology

Future Perspectives on the TNM Staging for Lung Cancer

Ramon Rami-Porta

Summary: The classification of lung cancer based on tumor, lymph node, and metastases has undergone several revisions since its proposal in 1966. The upcoming 9th edition is expected to combine this classification with other prognostic factors to provide a more personalized prognosis for individual patients. International collaboration is crucial in building a comprehensive database to achieve this objective.

CANCERS (2021)

Review Oncology

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer

Claudia Freitas et al.

Summary: Liquid biopsy is an emerging technology that shows potential in the screening and early detection of lung cancer. Various liquid biopsy-derived biomarkers have been identified, but their diagnostic performance and clinical applicability are still limited. Combining different biomarkers and using them in conjunction with other diagnostic tools hold promise, but further research is needed to define and validate the role of liquid biopsies in clinical practice.

FRONTIERS IN ONCOLOGY (2021)

Article Medicine, General & Internal

Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer

Sha-Sha Jiang et al.

Summary: The study found that CTCs categorized by EMT markers have good diagnostic value in lung cancer diagnosis, particularly the detection of E&M-CTCs warrants further study.

WORLD JOURNAL OF CLINICAL CASES (2021)

Article Cell Biology

Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer

Athina Markou et al.

Summary: The study revealed a high frequency of MCT4 overexpression in CTCs from early NSCLC patients, which was significantly associated with disease progression, suggesting its importance in the metastatic process and potential as a target for cancer therapy.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Letter Cardiac & Cardiovascular Systems

LYMPH NODE STATIONS COUNTS IN RETROSPECTIVE STUDIES-IMPORTANT END POINT, BUT INTERPRET WITH CAUTION

Peter J. Kneuertz et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)

Article Cardiac & Cardiovascular Systems

Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm

Brendon M. Stiles et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)

Editorial Material Cardiac & Cardiovascular Systems

Commentary: Intraoperative lymph node assessment by robotic, video-assisted thoracoscopic surgery, and thoracotomy: None meet the international recommendations

Diego Gonzalez-Rivas et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)

Article Cardiac & Cardiovascular Systems

Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer

Peter J. Kneuertz et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)

Article Cardiac & Cardiovascular Systems

Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study

Nicola Tamburini et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)

Article Oncology

High Frequency of Spread Through Air Spaces in Resected Small Cell Lung Cancer

Gouji Toyokawa et al.

ANTICANCER RESEARCH (2018)

Article Cardiac & Cardiovascular Systems

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer

Matthew P. Smeltzer et al.

ANNALS OF THORACIC SURGERY (2016)

Review Respiratory System

Liquid biopsy and NSCLC

Domenico Trombetta et al.

LUNG CANCER MANAGEMENT (2016)

Article Cardiac & Cardiovascular Systems

Audit of Lymphadenectomy in Lung Cancer Resections Using a Specimen Collection Kit and Checklist

Raymond U. Osarogiagbon et al.

ANNALS OF THORACIC SURGERY (2015)

Article Cardiac & Cardiovascular Systems

Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer

Paul De Leyn et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2014)

Article Oncology

Causes and Consequences of Deviation from Multidisciplinary Care in Thoracic Oncology

Raymond U. Osarogiagbon et al.

JOURNAL OF THORACIC ONCOLOGY (2011)

Review Oncology

Carcinoma In Situ at the Bronchial Resection Margin A Review

Eric Vallieres et al.

JOURNAL OF THORACIC ONCOLOGY (2011)

Article Critical Care Medicine

Classification of the Thoroughness of Mediastinal Staging of Lung Cancer

Frank Detterbeck et al.

CHEST (2010)

Editorial Material Oncology

Evarts A. Graham and the first pneumonectomy for lung cancer

Leora Horn et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Oncology

Margin and local recurrence after sublobar resection of non-small cell lung cancer

Amgad El-Sherif et al.

ANNALS OF SURGICAL ONCOLOGY (2007)

Article Cardiac & Cardiovascular Systems

A new device for the identification of lymph nodes at tung cancer surgery

Thomas F. Molnar

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)

Article Cardiac & Cardiovascular Systems

ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer

Didier Lardinois et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2006)

Article Oncology

Complete resection in lung cancer surgery: proposed definition

R Rami-Porta et al.

LUNG CANCER (2005)

Article Cardiac & Cardiovascular Systems

Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer

E Lim et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)